A broader portfolio of drugs with different mechanisms of action is not about replacing what we have, but about expanding our options to help more patients successfully and safely manage their weight in the long term. Jeffrey Kraft, MD MNT also spoke with Mir Ali, MD, a board certified general surgeon, bariatric surgeon and medical director of MemorialCare Surgical Weight Loss Center at Orange Coast Medical Center in Fountain Valley, CA, about this research
Not following these protocols can result in ineffective or contaminated results just like a restaurant serving spoiled food would lead to poor customer experiences
However, GLP-1 receptor agonists are not recommended if you: - Are pregnant - Are hypersensitive to GLP-1 - Have severe gastrointestinal conditions like inflammatory bowel disease (IBD) - Are at a higher risk of certain thyroid cancers If you have a history of pancreatitis, kidney failure, or gallbladder disease, GLP-1 receptor agonists may not be safe for you
CAD, Coronary Artery Disease
4(2): Xing H, Yue S, Qin R et al (2025) Recent Advances in Drug Development for Alzheimers Disease: A Comprehensive Review